Composite outcomes in randomized trials: greater precision but with greater uncertainty?
about
Statins for acute coronary syndromeFluid restriction and prophylactic indomethacin versus prophylactic indomethacin alone for prevention of morbidity and mortality in extremely low birth weight infantsStatins for acute coronary syndromePreoperative fasting for preventing perioperative complications in childrenDipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitusRosiglitazone for type 2 diabetes mellitusPioglitazone for type 2 diabetes mellitusPreoperative fasting for preventing perioperative complications in childrenImmunosuppressive agents for treating IgA nephropathyOutcomes, outcomes, every where, nor any stop to think?Outcome Reporting in Cardiac Surgery Trials: Systematic Review and Critical AppraisalWhen is birthweight at term abnormally low? A systematic review and meta-analysis of the association and predictive ability of current birthweight standards for neonatal outcomesConcordance of effects of medical interventions on hospital admission and readmission rates with effects on mortalityBiomarker validation: common data analysis concernsThe effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trialSPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsDesigning and analyzing clinical trials with composite outcomes: consideration of possible treatment differences between the individual outcomesEmerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetesOxygen Saturation Targets in Preterm Infants and Outcomes at 18-24 Months: A Systematic Review.Delta inflation: a bias in the design of randomized controlled trials in critical care medicine.Large sample inference for a win ratio analysis of a composite outcome based on prioritized components.Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations.A systematic review of cooling for neuroprotection in neonates with hypoxic ischemic encephalopathy - are we there yet?Effects of cognitive speed of processing training on a composite neuropsychological outcome: results at one-year from the IHAMS randomized controlled trial.Quality of reporting internal and external validity data from randomized controlled trials evaluating stents for percutaneous coronary interventionJUPITER: a few words of caution.An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome.Strength of association between umbilical cord pH and perinatal and long term outcomes: systematic review and meta-analysis.Computerised interpretation of fetal heart rate during labour (INFANT): a randomised controlled trial.Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? A retrospective cohort study.Early postnatal hypotension and developmental delay at 24 months of age among extremely low gestational age newborns.From short-term benefits to long-term outcomes: the evolution of clinical trials in pulmonary arterial hypertensionAnalysis of a composite endpoint with longitudinal and time-to-event data.Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMADelphi-consensus weights for ischemic and bleeding events to be included in a composite outcome for RCTs in thrombosis prevention.Clinical Trials in Veterinary Medicine: A New Era Brings New Challenges.Designing clinical trials for assessing the effects of cognitive training and physical activity interventions on cognitive outcomes: the Seniors Health and Activity Research Program Pilot (SHARP-P) study, a randomized controlled trialImpact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic reviewAssessing technological change in cardiothoracic surgery.
P2860
Q24193862-068DEB51-36BB-43B4-B1E1-657EDC43E71BQ24235346-DEC31CBD-5859-4377-9BF7-3455F6850C94Q24236697-7D3850B9-8D35-4677-BCCD-05A6558F3534Q24239976-48909E73-6B97-43FD-BF31-6415776D4640Q24243196-25A6F423-A7C7-40D9-8E74-048C18F6B311Q24243875-BDDC245C-21EF-4690-89D4-77CB58EA6D3DQ24244321-D4405F58-7B16-4E0D-9F1E-45811C372976Q24247006-CF6F6C4C-8BFE-417A-A699-C2FA4DF699FFQ24247680-FEE0A951-E070-4F8C-B00F-6C43388F7086Q24289467-09CA9F0A-9781-47E6-B1AD-FD44EC19D764Q26797479-2C233138-3003-4DFB-A60F-7D56AA8933F0Q26995449-1744D894-6FF7-4455-937C-FBCA31D73C06Q27022171-595EA24E-89C6-457A-8699-7C11A46D9D96Q27024057-532746C6-EAC9-4F45-BE60-D209F5DD7698Q28602669-E5F9E4F7-8A3A-43AE-A9FD-4340C35E1F89Q28710019-0A0DC661-9E0D-4C80-9087-E3143ABA7296Q28730540-704B4CCF-3D8D-4A0B-BD3C-1DBDD0FDF9D0Q28762629-BCB2C9AF-A48A-489E-9E86-8A1EB187C8A8Q30240081-B4DE2010-1816-4F2E-8BE4-BFA219E805E2Q30435820-CE7BD468-01EA-49D5-9191-49D571EA5DD1Q30689191-5369AA33-1778-40C5-8C6B-A4BC93153555Q31144449-2D5B024B-6878-464C-B7B2-5FEAB3D5F056Q33296921-1DAB6010-7151-4935-89CC-6678F48F162FQ33361498-5A01E346-8897-48BF-8B34-0C851D9EDCCAQ33428766-336B260F-FDFD-4FE7-8CEA-A620CA23EC16Q33557560-F3C82BD0-0410-4973-B9DC-E22D718524B4Q33569474-9FB5D580-6E69-4F04-B57F-2D2C527649EDQ33577720-51AC2C73-3022-4ED8-A4E8-DF29E1B4ACDBQ33628115-23B19369-0DA1-4BE7-9D13-ED58B5046C0EQ33628500-4E8B91B3-EBCE-4A41-ADA1-446A02389E9CQ33749078-9446425A-E6BD-44F3-B3EE-1662D4716885Q33806102-3432FD23-47F7-401A-A0D1-27336DF57718Q33826588-6F91B3CC-BE67-488B-BF4B-4C3F68B569A6Q33828797-D86F9662-9E49-43B2-8122-4C166992CA50Q33872146-E4B2C9AA-6971-48C0-9581-21CAA0B20B8FQ33900204-C56B7970-BEAC-4377-98A3-8C985AD24A5DQ33913028-F88C873D-D743-45E0-ABFF-860138610583Q33982372-52B1AA3F-DBBC-4707-A909-360348767971Q34073347-9C73F18F-9F0D-47C8-8F00-AF16D5498345Q34111912-D730A408-BD8E-4DB7-912D-6C6CBA966487
P2860
Composite outcomes in randomized trials: greater precision but with greater uncertainty?
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Composite outcomes in randomized trials: greater precision but with greater uncertainty?
@ast
Composite outcomes in randomized trials: greater precision but with greater uncertainty?
@en
type
label
Composite outcomes in randomized trials: greater precision but with greater uncertainty?
@ast
Composite outcomes in randomized trials: greater precision but with greater uncertainty?
@en
prefLabel
Composite outcomes in randomized trials: greater precision but with greater uncertainty?
@ast
Composite outcomes in randomized trials: greater precision but with greater uncertainty?
@en
P2093
P356
P1476
Composite outcomes in randomized trials: greater precision but with greater uncertainty?
@en
P2093
Carl Griffin
Joanne Eastaugh
P304
P356
10.1001/JAMA.289.19.2554
P407
P577
2003-05-01T00:00:00Z